Literature DB >> 26538212

Extended Application of the Hybrid Procedure in Neonates with Left-Sided Obstructive Lesions in an Evolving Cardiac Program.

Anas Taqatqa1, Karim A Diab1, Christopher Stuart1, Louis Fogg1, Michel Ilbawi1, Sawsan Awad1, Massimo Caputo1, Zahid Amin1, Ra-Id Abdulla1, Damien Kenny2, Ziyad M Hijazi1.   

Abstract

The hybrid approach to management of hypoplastic left heart syndrome (HLHS) was developed as an alternative to neonatal Norwood surgery, providing a less invasive initial palliation for HLHS. We describe our experience in extending the concept of the hybrid procedure to palliate neonates with anatomically compromised systemic arterial blood flow in a variety of congenital cardiac anomalies and supporting its application as first-line palliation in centers developing their HLHS programs. Retrospective review of patients undergoing therapy for HLHS at a single institution from June 2008 to December 2014 was performed. Subject demographics, clinical and procedural data, along with follow-up, were collected. Thirteen patients had initial hybrid palliation for HLHS during the time frame indicated at a median age of 8 days (range 1-29 days) and median weight of 3.4 kg (range 2.4-4.6 kg). Diagnoses included typical HLHS (n = 6), right-dominant unbalanced atrioventricular septal defect with arch hypoplasia (n = 4), double outlet right ventricle [subpulmonic VSD (n = 1) and intact ventricular septum (n = 1)] with hypoplastic transverse aortic arch and borderline left ventricular dimensions. Standard approach with bilateral pulmonary artery banding and ductal stenting was carried out in all thirteen patients. Two patients required two ductal stents at the time of index procedure. There were no intraprocedural complications. Median intubation length post-procedure was 4 days (range 1-74 days). Median hospital stay post-procedure was 47 days (range 15-270 days). The overall mortality rate on follow-up through comprehensive stage 2 over the 6-year experience was 38 % (5 out of 13). Of note, the mortality rate was significantly lower in the latter 3 years of the study period when the procedure was adopted as a primary palliation for HLHS (14 % or 1 out of 7) compared to the initial 3-year period when it was reserved for higher risk cohorts (67 % or 4 out of 6). Median time to subsequent surgery was 3 months (range 1-4 months). One patient required further ductal stenting on follow-up and developed subsequently airway compression. On median follow-up of 24 months, two patients required pulmonary artery arterioplasty. The hybrid procedure may be used for palliation for a variety of cardiac lesions to avoid high-risk surgery in the neonatal period. This approach may be also an alternative in centers performing lower number of Norwood surgery, which has been associated with higher mortality.

Entities:  

Keywords:  Borderline LV size; Hybrid procedure; Hypoplastic left heart syndrome

Mesh:

Year:  2015        PMID: 26538212     DOI: 10.1007/s00246-015-1301-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  28 in total

1.  The effect of surgical case volume on outcome after the Norwood procedure.

Authors:  Paul A Checchia; Jamie McCollegan; Noha Daher; Nikoleta Kolovos; Fiona Levy; Barry Markovitz
Journal:  J Thorac Cardiovasc Surg       Date:  2005-04       Impact factor: 5.209

2.  Unexpected death after reconstructive surgery for hypoplastic left heart syndrome.

Authors:  W T Mahle; T L Spray; J W Gaynor; B J Clark
Journal:  Ann Thorac Surg       Date:  2001-01       Impact factor: 4.330

3.  Normal interstage growth after the norwood operation associated with interstage home monitoring.

Authors:  David A Hehir; Nancy Rudd; Julie Slicker; Kathleen A Mussatto; Pippa Simpson; Shun-Hwa Li; Michele A Frommelt; James S Tweddell; Nancy S Ghanayem
Journal:  Pediatr Cardiol       Date:  2012-04-20       Impact factor: 1.655

4.  Cause, timing, and location of death in the Single Ventricle Reconstruction trial.

Authors:  Richard G Ohye; Julie V Schonbeck; Pirooz Eghtesady; Peter C Laussen; Christian Pizarro; Peter Shrader; Deborah U Frank; Eric M Graham; Kevin D Hill; Jeffrey P Jacobs; Kirk R Kanter; Joel A Kirsh; Linda M Lambert; Alan B Lewis; Chitra Ravishankar; James S Tweddell; Ismee A Williams; Gail D Pearson
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-15       Impact factor: 5.209

5.  Single-ventricle infant home monitoring programs: outcomes and impact.

Authors:  David A Hehir; Nancy S Ghanayem
Journal:  Curr Opin Cardiol       Date:  2013-03       Impact factor: 2.161

6.  Hybrid versus Norwood strategies for single-ventricle palliation.

Authors:  Kenji Baba; Yasuhiro Kotani; Devin Chetan; Rajiv R Chaturvedi; Kyong-Jin Lee; Lee N Benson; Lars Grosse-Wortmann; Glen S Van Arsdell; Christopher A Caldarone; Osami Honjo
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

Review 7.  A review of ductal stenting in hypoplastic left heart syndrome: bridge to transplantation and hybrid stage I palliation.

Authors:  D J DiBardino; D B McElhinney; A C Marshall; E A Bacha
Journal:  Pediatr Cardiol       Date:  2007-10-03       Impact factor: 1.655

8.  Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve.

Authors:  Mark Galantowicz; John P Cheatham; Alistair Phillips; Clifford L Cua; Timothy M Hoffman; Sharon L Hill; Roberta Rodeman
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

9.  Hybrid management for hypoplastic left heart syndrome : an experience from Brazil.

Authors:  Carlo B Pilla; Carlos A C Pedra; Aldemir J S Nogueira; Marcelo Jatene; Luis Carlos B Souza; Simone R F Pedra; Carlos Ferreiro; Claudia P Ricachinevsky; Fernando A Lucchese
Journal:  Pediatr Cardiol       Date:  2007-12-13       Impact factor: 1.655

10.  Fifteen-year single center experience with the "Giessen Hybrid" approach for hypoplastic left heart and variants: current strategies and outcomes.

Authors:  Dietmar Schranz; Anna Bauer; Bettina Reich; Blanka Steinbrenner; Sabine Recla; Dorle Schmidt; Christian Apitz; Josef Thul; Klaus Valeske; Jürgen Bauer; Matthias Müller; Christian Jux; Ina Michel-Behnke; Hakan Akintürk
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

View more
  2 in total

1.  Hybrid Strategy for High-Risk Neonates with Interrupted Aortic Arch: A Can Well Worth Kicking?

Authors:  Eva Kapravelou; David Anderson; Gareth J Morgan
Journal:  Int J Angiol       Date:  2017-04-19

Review 2.  What Interventional Cardiologists Are Still Leaving to the Surgeons?

Authors:  Worakan Promphan; Shakeel A Qureshi
Journal:  Front Pediatr       Date:  2016-06-13       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.